U.S. MARKETS FOR PHARMACOLOGIC AND DEVICE-BASED APPROACHES TO PAIN MANAGEMENT

132 Pages | 30 Exhibits | 2016 Analysis | Forecasts Through 2020 Product Family: Market Reports




OVERVIEW:
More than 40% of people in the U.S. say they have experienced recent pain, with 8% suffering from chronic pain. Direct healthcare costs associated with the treatment of pain total nearly $300 billion annually, with indirect costs such as reduced worker productivity contributing another $300 billion in costs. Multidisciplinary pain management plans may involve the use of pharmacologic, device-based, or alternative therapies; a combination of these modalities often is required to achieve optimum pain relief, particularly for those suffering from chronic pain.

This new report by Medtech Insight presents a detailed overview of the U.S. pain management market. Major topics covered by this report include nonprescription analgesics (e.g., systemic drugs such as acetaminophen and NSAIDs, as well as topical drugs such as amino acids and esters, capsaicin, and methyl and trolamine salicylates), prescription analgesics (e.g., prescription NSAIDs, opioids, combination drugs, antimigraine drugs, adjuvant analgesics, and anesthetics), electrical stimulators (e.g., TENS units and neurostimulators such as occipital nerve, neuromuscular, and spinal cord stimulators), and infusion pumps (e.g., implantable and external pumps).

TABLE OF CONTENTS:
EXECUTIVE SUMMARY

i. Pain Management Pharmaceuticals
	a. Nonprescription Analgesics and Anesthetics
		i. Nonprescription Systemic Analgesics
ii. Nonprescription Topical Analgesics
	b. Prescription Analgesics and Anesthetics
		i. Prescription Non-Steroidal Anti-Inflammatory Drugs
ii. Opioid Analgesics
iii. Opioid/Nonopioid Combination Analgesics
iv. Antimigraine Analgesics
v. Adjuvant Analgesics
vi. General, Regional, and Local Anesthetics
	c. Market Forecast
ii. Pain Management Devices
	a. Electrical Stimulators
		i. Transcutaneous Electrical Nerve Stimulators
ii. Neurostimulators
	b. Analgesia Infusion Pumps
		i. Implantable Analgesia Infusion Pumps
		ii. External Analgesia Infusion Pumps
	c. Market Forecast
iii. Combined Market Forecast



Exhibit ES-1: Pain Management Pharmaceuticals, Market Forecast, 2015-2020
Exhibit ES-2: Pain Management Devices, Market Forecast, 2015-2020
Exhibit ES-3: Pain Management Pharmaceuticals and Devices, Combined Market Forecast, 2015 through 2020

1. PAIN MANAGEMENT PHARMACEUTICALS

1.1 Market Analysis
	1.1.1 Nonprescription Analgesics and Anesthetics
		1.1.1.1 Combined Market Forecast
		1.1.1.2 Nonprescription Systemic Analgesics
			1.1.1.2.1 Acetaminophen
			1.1.1.2.2 Nonprescription Nonsteroidal Anti-Inflammatory Drugs
			1.1.1.2.3 Market Forecast
			1.1.1.2.4 Competitive Analysis
		1.1.1.3 Nonprescription Topical Analgesics and Anesthetics
			1.1.1.3.1 Amino Amides and Esters
			1.1.1.3.2 Capsaicin
			1.1.1.3.3 Methyl and Trolamine Salicylates
			1.1.1.3.4 Topical Patches
			1.1.1.3.5 Market Forecast
			1.1.1.3.6 Competitive Analysis
	1.1.2 Prescription Analgesics and Anesthetics
		1.1.2.1 Combined Market Forecast
		1.1.2.2 Prescription Nonsteroidal Anti-Inflammatory Drugs
			1.1.2.2.1 Acetic Acid Derivatives
			1.1.2.2.2 Anthranilic Acid Derivatives
			1.1.2.2.3 Cyclooxygenase-2 Selective Inhibitors
			1.1.2.2.4 Enolic Acid Derivatives
			1.1.2.2.5 Propionic Acid Derivatives
			1.1.2.2.6 Salicylic Acid Derivatives
			1.1.2.2.7 Market Forecast
			1.1.2.2.8 Competitive Analysis
		1.1.2.3 Opioid Analgesics
			1.1.2.3.1 Buprenorphine
			1.1.2.3.2 Butorphanol
			1.1.2.3.3 Codeine
			1.1.2.3.4 Fentanyl
			1.1.2.3.5 Hydromorphone
			1.1.2.3.6 Levorphanol
			1.1.2.3.7 Meperidine
			1.1.2.3.8 Morphine
			1.1.2.3.9 Nalbuphine
			1.1.2.3.10 Oxycodone
			1.1.2.3.11 Oxymorphone
			1.1.2.3.12 Pentazocine
			1.1.2.3.13 Propoxyphene
			1.1.2.3.14 Remifentanil
			1.1.2.3.15 Tramadol
			1.1.2.3.16 Tapentadol
			1.1.2.3.17 Hydrocodone
			1.1.2.3.18 Market Forecast
			1.1.2.3.19 Competitive Analysis
		1.1.2.4 Opioid/Nonopioid Combination Analgesics
			1.1.2.4.1 Market Forecast
			1.1.2.4.2 Competitive Analysis
		1.1.2.5 Antimigraine Analgesics
			1.1.2.5.1 Diclofenac
			1.1.2.5.2 Dihydroergotamine
			1.1.2.5.3 Divalproex Sodium
			1.1.2.5.4 Triptans
			1.1.2.5.5 Market Forecast
			1.1.2.5.6 Competitive Analysis
		1.1.2.6 Adjuvant Analgesics
			1.1.2.6.1 Anticonvulsants
			1.1.2.6.2 Antidepressants
			1.1.2.6.3 Corticosteriods
			1.1.2.6.4 Market Forecast
			1.1.2.6.5 Competitive Analysis
		1.1.2.7 General, Regional, and Local Anesthetics
			1.1.2.7.1 Inhalation General Anesthetics
			1.1.2.7.2 Intravenous General Anesthetics
			1.1.2.7.3 Anesthetics Used in Balanced Anesthesia
			1.1.2.7.4 Regional/Local Anesthetics
			1.1.2.7.5 Market Forecast
			1.1.2.7.6 Competitive Analysis
	1.1.3 Combined Market Forecast

Exhibit 1-1: Nonprescription Analgesics and Anesthetics, Combined Market Forecast, 2015-2020
Exhibit 1-2: Nonprescription Systemic Analgesics, Market Forecast, 2015-2020
Exhibit 1-3: 2015, Nonprescription Systemic Analgesics Market, Share by Supplier
Exhibit 1-4: Nonprescription Topical Analgesics/Anesthetics, Market Forecast, 2015-2020
Exhibit 1-5: 2015, Nonprescription Topical Analgesics/Anesthetics Market, Share by Supplier
Exhibit 1-6: Prescription Analgesics and Anesthetics, Combined Market Forecast, 2015-2020
Exhibit 1-7: Prescription Nonsteroidal Anti-Inflammatory Drugs, Market Forecast, 2015-2020
Exhibit 1-8: 2015, Prescription Nonsteroidal Anti-Inflammatory Drugs Market, Share by Supplier
Exhibit 1-9: Prescription Opioid Analgesics, Market Forecast, 2015-2020
Exhibit 1-10: 2015, Prescription Opioid Analgesics Market, Share by Supplier
Exhibit 1-11: Prescription Opioid/Nonopioid Combination Analgesics, Market Forecast, 2015-2020
Exhibit 1-12: Prescription Antimigraine Analgesics, Market Forecast, 2015-2020
Exhibit 1-13: 2015, Prescription Antimigraine Analgesics Market, Share by Supplier
Exhibit 1-14: Prescription Adjuvant Analgesics, Market Forecast, 2015-2020
Exhibit 1-15: 2015, Prescription Adjuvant Analgesics Market, Share by Supplier
Exhibit 1-16: General, Regional, and Local Anesthetics, Market Forecast, 2015-2020
Exhibit 1-17: 2015, General, Regional, and Local Anesthetics Market, Share by Supplier
Exhibit 1-18: Pain Management Pharmaceuticals, Combined Market Forecast, 2015-2020

2. PAIN MANAGEMENT DEVICES

2.1 Electrical Stimulators
	2.1.1 Transcutaneous Electrical Nerve Stimulators
	2.1.2 Neurostimulators
		2.1.2.1 Occipital Nerve Stimulation
		2.1.2.2 Neuromuscular Stimulators
		2.1.2.3 Spinal Cord Stimulators
		2.1.2.4 Market Forecast
		2.1.2.5 Competitive Analysis
		2.1.2.6 Emerging Technologies
			2.1.2.6.1 Nevro
			2.1.2.6.2 Stimwave
2.2 Analgesia Infusion Pumps
	2.2.1 Implantable Analgesia Infusion Pumps
		2.2.1.1 Market Forecast
		2.2.1.2 Competitive Analysis
	2.2.2 External Analgesia Infusion Pumps
		2.2.2.1 Nerve Block
		2.2.2.2 Patient-Controlled Analgesia Infusion Pumps
		2.2.2.3 Products
		2.2.2.4 Market Forecast
		2.2.2.5 Competitive Analysis
2.3 Combined Market Forecast

Exhibit 2-1: Proposed Fourth Step of the World Health Organization Analgesic Ladder
Exhibit 2-2: Selected Painful Conditions Appropriate for Electrical Stimulation Therapy
Exhibit 2-3: Neurostimulators for the Treatment of Pain, Market Forecast, 2015-2020
Exhibit 2-4: 2015, Implantable Spinal Cord Stimulators Market, Share by Supplier
Exhibit 2-5: Implantable Infusion Pumps, Market Forecast, 2015-2020
Exhibit 2-6: 2015, Implantable Analgesia Infusion Pumps Market, Share by Supplier
Exhibit 2-7: External Analgesia Infusion Pumps, Market Forecast, 2015-2020
Exhibit 2-8: 2015, External Analgesia Infusion Pumps Market, Share by Supplier
Exhibit 2-9: Pain Management Devices, Combined Market Forecast, 2015-2020

APPENDIX A:  COMPANY LISTING

APPENDIX B:  BIBLIOGRAPHY


COMPANIES COVERED:

  1. Abbott Laboratories
  2. AbbVie, Inc.
  3. Acura Pharmaceuticals, Inc.
  4. Akorn, Inc.
  5. Allergan, Inc.
  6. AstraZeneca PLC
  7. Avanir Pharmaceuticals, Inc.
  8. Baxter Healthcare, Inc./Baxter International, Inc.
  9. Bayer AG
  10. Bayer HealthCare AG/Bayer AG
  11. B. Braun Medical, Inc./B. Braun Melsungen AG
  12. Beutlich Pharmaceuticals LLC
  13. Blue Spring International LLC
  14. Boston Scientific Corporation
  15. CareFusion Corporation/BD
  16. CetyLite Industries, Inc.
  17. Chattem, Inc./Sanofi LLC
  18. CoLucid Pharmaceuticals, Inc.
  19. Crystal Genomics, Inc.
  20. Depomed, Inc.
  21. DePuy Synthes, Inc./Johnson & Johnson
  22. Durect Corporation
  23. Egalet Corporation
  24. Eli Lilly and Company
  25. Endo Pharmaceutical Holdings, Inc./Endo International PLC
  26. GlaxoSmithKline PLC
  27. Halyard Health, Inc.
  28. Haw Par Corporation
  29. Hisamitsu America, Inc./Hisamitsu Pharmaceutical Company, Inc.
  30. Horizon Pharma, Inc.
  31. Hospira/Pfizer, Inc.
  32. Impax Pharmaceuticals, Inc.
  33. IntelGenx Corporation
  34. Iroko Pharmaceuticals, Inc.
  35. Janssen Pharmaceuticals, Inc./Johnson & Johnson
  36. Jazz Pharmaceuticals, Inc.
  37. Johnson & Johnson
  38. Kramer Laboratories, Inc.
  39. Mallinckrodt PLC
  40. McNeil Consumer Healthcare/Johnson & Johnson
  41. The Medicines Company
  42. Medtronic, Inc.
  43. Medtronic Minimally Invasive Therapies/Medtronic, Inc.
  44. The Mentholatum Company, Inc.
  45. Merck & Company, Inc.
  46. Mission Pharmacal Company
  47. Moog, Inc.
  48. Nevro Corporation
  49. Nnodum Pharmaceuticals Corporation
  50. Novartis AG
  51. Nuvo Pharmaceuticals, Inc.
  52. OptiNose, Inc.
  53. Otis Clapp & Buffington Pharmaceuticals, Inc.
  54. Pacira Pharmaceuticals, Inc.
  55. Pernix Therapeutics, Inc.
  56. Pfizer, Inc.
  57. Piramal Healthcare LTD
  58. Prestige Brands, Inc.
  59. Procter & Gamble Company
  60. Purdue Pharma LP
  61. Red Hill Biopharma LTD
  62. Relmada Therapeutics, Inc.
  63. Roche Pharmaceuticals/F. Hoffman-La Roche AG
  64. Sanofi LLC
  65. Sentnyl Therapeutics, Inc.
  66. Shionogi & Company LTD
  67. Smiths Medical/Smiths Group PLC
  68. Stellar Health Products, Inc.
  69. Stimwave LLC
  70. St. Jude Medical, Inc.
  71. Stryker Corporation
  72. Sultan Healthcare, Inc.
  73. Teva Pharmaceutical Industries LTD
  74. Valeant Pharmaceuticals International, Inc.
  75. Walkmed Infusion LLC
  76. Zogenix, Inc.
Contact Us

Need help finding medtech research? Let us help you!